Investigational drug · Phase 3
KP-100IT
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acute Spinal Cord Injury (SCI).
Phase 3Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
3
Any phase or sponsor naming "KP-100IT"
First trial start
2026
Jul 31, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "KP-100IT", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acute Spinal Cord Injury (SCI)
Largest trials
Live from ClinicalTrials.gov: studies naming "KP-100IT" as an intervention, largest first.
Kringle Pharma, Inc.Industry
NCT02193334 · 45 participants · Start Jun 30, 2014 · Primary completion Dec 21, 2017
Drug: KP-100IT; Placebo · For: Spinal Cord Injuries
Sites: Iizuka, Japan; Bibai, Japan
- Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord InjuryPivotal-lookingStatus unknown
Kringle Pharma, Inc.Industry
NCT04475224 · 25 participants (planned) · Start Jul 13, 2020 · Primary completion Dec 31, 2022
Drug: KP-100IT · For: Acute Spinal Cord Injury
Sites: Iizuka, Japan; Bibai, Japan; Kobe, Japan · 5 sites in all
- Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord InjuryPivotal-lookingNot yet recruiting
Kringle Pharma, Inc.Industry
NCT07722962 · 10 participants (planned) · Start Jul 31, 2026 · Primary completion Dec 31, 2028
Drug: KP-100IT · For: Acute Spinal Cord Injury (SCI)
Sites: Iizuka, Japan; Bibai, Japan; Musashimurayama, Japan
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.